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How steroid hormones shape animal growth remains
poorly understood. In Drosophila, the main steroid
hormone, ecdysone, limits systemic growth during
juvenile development. Here we show that ecdysone
controls animal growth rate by specifically acting
on the fat body, an organ that retains endocrine
and storage functions of the vertebrate liver and
fat. We demonstrate that fat body-targeted loss of
function of the Ecdysone receptor (EcR) increases
dMyc expression and its cellular functions such as
ribosome biogenesis. Moreover, changing dMyc
levels in this tissue is sufficient to affect animal
growth rate. Finally, the growth increase induced by
silencing EcR in the fat body is suppressed by cosi-
lencing dMyc. In conclusion, the present work
reveals an unexpected function of dMyc in the
systemic control of growth in response to steroid
hormone signaling.
INTRODUCTION
Growth is a discontinuous process that needs to be coordinated
with the developmental program. In many species, growth is
restricted to the juvenile period. Passage into adulthood is
accompanied by the acquisition of sexual maturity (maturation)
and rapid changes in growth control, leading to a systemic arrest
of body growth. The relationships between the onset of matura-
tion and the regulation of growth remain poorly understood.
In holometabolous insects, growth and maturation are tempo-
rally distinct. Growth is mainly restricted to the larval period and
maturation occurs during metamorphosis or pupal development.
Tissue growth relies on the insulin/IGF (insulin-like growth factor)
signaling pathway (IIS), a highly conserved pathway that couples
nutrition with growth. Drosophila has a conserved IIS system
with seven insulin-like peptides named Dilps, a unique insulin
receptor (dInR), and a conserved cascade of intracellular effec-
tors (Ge´minard et al., 2006). In parallel to the canonical InR
pathway, the target of rapamycin (TOR) pathway promotes cell
growth through its action on translational initiation, ribosome
biogenesis, nutrient storage, endocytosis, and autophagy
(reviewed in Arsham and Neufeld, 2006; Wullschleger et al.,1012 Developmental Cell 18, 1012–1021, June 15, 2010 ª2010 Elsev2006; Guertin and Sabatini, 2007). Multiple molecular crosstalks
have been established between the TOR and InR signaling path-
ways, ensuring that cells integrate both systemic and local cues
in their growth program. Other growth inducers have been iden-
tified in multicellular organisms, among them the Myc family of
transcription factors (reviewed in Eilers and Eisenman, 2008).
In mammalian cells, activity of the Myc proteins is associated
with cell growth and proliferation, inhibition of terminal differenti-
ation, and apoptosis (Grandori et al., 2000). Consistent with its
role in growth control, Myc is a potent regulator of many compo-
nents of the translation apparatus. It activates RNA polymerase
III, rRNA synthesis, ribosome biosynthesis genes, and transla-
tion initiation factors. In line with their common action on ribo-
some biosynthesis and translation initiation, recent data suggest
a link between the IIS/TOR network and Myc. In specific tissues,
expression of theDrosophila Myc ortholog dMyc is repressed by
dFoxO, a transcription factor that is inhibited by the activation of
IIS. In addition, TOR signaling regulates dMyc protein levels and
the activation of dMyc target genes (Teleman et al., 2008).
In parallel to the molecular machinery that promotes larval
tissue growth, a humoral clock times the different developmental
stages. In both vertebrates and insects, maturation is triggered
by steroid hormones. In Drosophila, larvae progress through
a series of molts, the duration of which is determined by a pulse
of the steroid hormone 20-hydroxyecdysone (20E, also referred
to as ecdysone; reviewed by Thummel, 1996). At the end of larval
development, a strong induction of ecdysone production
promotes growth arrest and the transition to pupal development.
Like vertebrate steroids, ecdysone acts through members of the
nuclear receptor superfamily that function as ligand-regulated
transcription factors. The ecdysone receptor is a heterodimer
consisting of two nuclear receptors, EcR and Ultraspiracle
(Usp) (reviewed by King-Jones and Thummel, 2005). Ecdysone
rapidly induces early response genes such as those encoding
the nuclear receptors E74, E75, and Broad Complex (BR-C),
a family of transcription factors. Subsequently, late genes that
control the biological responses to each ecdysone pulse are
induced, leading to the morphological changes specific to
each developmental stage.
Many studies suggest that growth and developmental timing
are interconnected to establish final body size. Suppression of
the prothoracicotropic hormone (PTTH, the hormone that stim-
ulates ecdysone production in the larva) results in a delayed
transition to pupal development. As a consequence, animals
benefit from a longer larval growth period and eclose as largerier Inc.
Figure 1. EcR Signaling Is Required for Tissue Growth and Cell
Proliferation
(A) Ratios between the areas of clonal cells overexpressing the indicated trans-
genes (GFP+) versus the wild-typecells (GFP) using the flip-out Gal4 technique.
In the fat body, EcR loss of function (EcRF645, EcR-RNAi, and USP-RNAi) signif-
icantly decreases the cell size compared to control (GFP overexpression). Over-
expression of a dominant-negative form of PI3K (PI3KDN) gives a similar effect. n,
number of GFP+ cells measured. Error bars represent standard error of the mean
(SEM); **p < 0.01 versus control (GFP-expressing cells).
(B) Clones were induced at 48 hr AED. Discs were fixed at wandering stages (115
hr AED). Twenty-nine random clones of each genotype were measured and
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Developmflies (McBrayer et al., 2007). A manipulation of the ras/raf/
MAPK signaling pathway in the prothoracic gland (PG, the
larval site for ecdysone synthesis) modifies the timing of the
ecdysone peak, the timing of the larval/pupal transition, and
the size of the adults (Caldwell et al., 2005). Drastic changes
in PI3-kinase activity in this tissue lead to similar effects (Mirth
et al., 2005).
Last, besides its ability to time developmental transitions, the
molting hormone ecdysone has also been shown to specifically
control the speed at which animals grow, or growth rate. Indeed,
changes in circulating ecdysone levels during larval develop-
ment affect IIS activity in larval tissues and influence final body
size (Colombani et al., 2005). This indicates that IIS and ecdy-
sone signaling pathways carry antagonistic actions that estab-
lish the animal growth rate. The physiology and the molecular
aspects of the interaction between these two major pathways
remain unknown.
In the present study, we show that the fat body, the functional
homolog of vertebrate liver and adipose tissue, acts as a unique
relay tissue for the control of larval growth by circulating ecdy-
sone. The repression of IIS by ecdysone signaling is not required
in fat cells to mediate ecdysone-dependent growth inhibition.
RNA profiling of dissected fat bodies revealed that EcR signaling
represses the Drosophila dMyc gene and its downstream
targets. Furthermore, the downregulation of dMyc in fat cells is
critical for growth inhibition by ecdysone. We propose a model
whereby the rise of ecdysone levels at the end of the juvenile
period represses dMyc expression in the fat body. This inhibition
restricts ribosome biosynthesis and translation efficiency in fat
cells, and induces a general pause in the growth program that
precedes entry into metamorphosis.RESULTS
Cell Proliferation and Tissue Growth Are Reduced upon
EcR Loss of Function
We previously showed that circulating ecdysone impedes the
larval growth rate through an antagonistic interaction with IIS
(Colombani et al., 2005). Because IIS is an important regulator
of cell growth, we tested the cell-autonomous effects of reducing
EcR signaling on cell size. Surprisingly, clonal silencing of EcR
and Usp or clonal expression of a dominant-negative form of
EcR (EcRF645A) in the fat body led to a reduction of cell size,
despite higher levels of IIS (Figure 1A; see Figures S1A and
S1B, available online, for the characterization of the UAS-EcR-
RNAi line). The same analysis made in imaginal tissues also
showed reduced growth in clones upon EcR loss of function
(Figure 1B). More specifically, the cell-doubling time of imaginal
cells was strongly increased in clones expressing EcRF645A and
moderately affected upon EcR silencing (Figure 1C). These
results demonstrate that despite an antagonistic action on IIS,plotted individually in order of increasing size. Controls are GFP-expressing
clones. Values for median and average are indicated.
(C) Clones were induced at 72 hr AED and analyzed after fixation at wandering
stages. The distribution of the number of cells per clone as a percentage of the
total number of clones for each genotype is shown. The median cell-doubling
time (CDT) is shown.
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Figure 2. The 20E Growth-Inhibitory Signal
Is Only Relayed by the Larval Fat Body to
Larval Peripheral Tissues
(A) During larval development, silencing EcR
specifically in the fat body using three different
Gal4 drivers (cg >, ppl >, and r4 >) increases pupal
volume compared to controls (W, EcR-RNAi or
cg >, ppl >, and r4 > crossed with wild-type flies).
Removing EcR in the muscles (MHC > EcR-RNAi),
the imaginal discs (esc > EcR-RNAi), the gut (cad >
EcR-RNAi, myo1D > EcR-RNAi), or the central
nervous system (elav > EcR-RNAi) does not
increase pupal size. Upper brackets indicate the
genotypes that are compared.
(B–E) Silencing EcR in the fat body using the Gal4
drivers ppl > (B), cg > (C), and r4 > (D) but not
myo1D > (E) prevents 20E feeding-induced growth
inhibition. Experiments were all carried out at
25C, except for cg > at 29C (E). myo1D > is
used as a control for the gut expression of ppl >.
n, number of measured pupae. Graphs represent
mean ± SEM. *p < 0.05; **p < 0.01 versus controls.
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larval and imaginal tissues. Therefore, general growth inhibition
exerted by ecdysone does not rely on the cell-autonomous
downregulation of IIS by EcR signaling.
The Fat Body Is the Unique Relay for the Growth-
Inhibitory Function of 20E
Larvae with high ecdysone titers due to increased ecdysone
synthesis in the PG or following 20E feeding grow slower.
Conversely, ubiquitoussilencingofEcRduring larvaldevelopment
accelerates growth (Colombani et al., 2005). This effect could be
recapitulated by silencing EcR specifically in fat cells, suggesting
that the fat body could be the only relay for ecdysone-induced
growth inhibition (Colombani et al., 2005). In order to test
this hypothesis, we silenced EcR in various tissues using1014 Developmental Cell 18, 1012–1021, June 15, 2010 ª2010 Elsevier Inc.tissue-specific GAL4 drivers. Three
different GAL4 lines highly expressed in
this tissue, r4-GAL4 (r4 >), cg-GAL4
(cg >), and ppl-GAL4 (ppl >), induced an
increase in pupal volume when crossed
with the UAS-EcR-RNAi line (Figure 2A)
without affecting developmental timing
(Figure S2A). A similar increase in pupal
volume could be observed in cg >
UAS-EcRF645A and cg > UAS-USP-RNAi
animals (data not shown). All these condi-
tions are pupal lethal. By contrast, no
pupal volume increase was observed
when EcR was silenced either in the gut,
imaginal tissues, muscles, or nervous
system (Figure 2A).
If the fat body is the unique relay for
ecdysone-mediated growth inhibition,
we would expect that growth inhibition
observed upon 20E feeding could be sup-
pressed by specifically reducing EcRsignaling in fat cells. To test this, we fed 20E to larvae where
EcR was specifically silenced in the fat body using either ppl >,
cg >, or r4 >. Under all conditions, we observed that silencing
EcR in the fat body of ppl > EcR-RNAi, r4 > EcR-RNAi, or cg >
EcR-RNAi larvae prevented the growth inhibition provoked by
20E feeding (Figures 2B–2D). As a control, specific EcR silencing
in the gut (myo1D > EcR-RNAi) did not prevent 20E from gener-
ating smaller pupae (Figure 2E). In conclusion, our data indicate
that the fat body is the unique relay tissue where EcR signaling
nonautonomously regulates the growth rate of the larva.
Overgrowth Induced by EcR Loss of Function
Does Not Rely on IIS in Fat Body Cells
As previously shown, EcR signaling antagonized IIS in the fat body
(Colombani et al., 2005) (Figure S1). This inhibition of IIS in fat cells
Figure 3. Inhibition of IIS by EcR in Fat Body Cells
Does Not Contribute to Systemic Growth
(A) Measurement of pupal volume shows no difference
between P0206 > PI3KDN and P0206, cg > PI3KDN, indicating
that blocking IIS in the fat body does not prevent overgrowth
due to decreased ecdysone circulating levels.
(B) Graph showing that the pupal volume increase observed in
cg > EcR-RNAi animals is unaltered by IIS inhibition in the fat
body of cg > EcR-RNAi, PI3K-RNAi animals.
(C) Conversely, P0206 > PTEN-RNAi animals are smaller due
to elevated ecdysone levels. Adding the cg > driver in this
genetic background does not modify the phenotype.
(D) In addition, silencing dFoxO in the fat body using the ppl >
driver does not prevent the growth decrease due to 20E
feeding. n, number of measured pupae. Graphs represent
mean ± SEM; **p < 0.01.
(E) qRT-PCR for detecting dInR transcripts in nonadipose
larval tissues dissected at wandering stage. Fold changes
(f.c.) are relative to control (ppl >W orW>EcR-RNAi) and error
bars represent SEM; *p < 0.05 and **p < 0.01 versus control.
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signaling. To test this, we used conditions where ecdysone
biosynthesis is impaired by a reduction of PI3-kinase activity in
the PG (P0206 > PI3KDN). In these animals, circulating levels of
20E are reduced and larvae develop into larger pupae and adults
(Colombani et al., 2005). By adding the fat body-specific driver
cg-GAL4 to this genetic background, we could carry IIS inhibition
in two organs: in the PG, where this induced a reduction of ecdy-
sone production (see Colombani et al., 2005), and in fat cells,
where this counteracted the elevation of PI3K activity (Figures
S3A and S3B). This way, we could evaluate whether downregula-
tion of IIS in the fat body could rescue the overgrowth phenotypeDevelopmental Cell 18,obtained upon limited synthesis of 20E. P0206 > ,
cg > PI3KDN animals were not different in size from
P0206 > PI3KDN, indicating that reducing IIS in fat
cells cannot prevent the increase in pupal size
(Figure 3A). To confirm this result, we silenced both
PI3K and EcR specifically in the fat body (cg >
EcR-RNAi, > PI3K-RNAi; see Figures S3C and S3D
for EcR and dFoxO immunostainings). Again, the
overgrowth phenotype observed uponEcR silencing
in the fat body was unaffected by reducing IIS in the
same place (Figure 3B). We then carried out the
converse experiment, where 20E production was
increased by silencing PTEN, a negative regulator
of IIS, specifically in the PG (P0206 > PTEN-RNAi).
As expected, this led to smaller pupae (Figure 3C).
Adding the cg > driver in the P0206 > PTEN-RNAi
genetic background overactivated IIS in fat body
cells as visualized by dFoxO staining (Figures S3E
and S3F), but did not interfere with the pupal volume
(Figure 3C). Therefore, despite its elevated activity
under conditions of reduced EcR signaling, fat-
specific IIS is not responsible for the observed
systemic growth increase.
We then further evaluated the potential role of fat-
specific dFoxO in EcR-mediated growth control.
Indeed, it was shown previously that clonal inacti-vation of EcR leads to a relocalization of dFoxO in the cytoplasm
of fat cells (Rusten et al., 2004; Colombani et al., 2005). This
could reflect a direct interaction of EcR/Usp with the transcrip-
tion factor dFoxO, without involving IIS. We therefore tested
directly the effect of reducing dFoxO expression on the growth
inhibition mediated by 20E feeding. Interestingly, 20E-mediated
growth inhibition was still observed when fat dFoxO expression
is reduced by RNAi, indicating that, although regulated by EcR
activity, fat dFoxO does not contribute to EcR-mediated
systemic growth inhibition (Figure 3D).
Nevertheless, IIS could still be involved in the growth increase
observed upon low fat body EcR expression, acting as a general1012–1021, June 15, 2010 ª2010 Elsevier Inc. 1015
Figure 4. EcR Regulates the Expressions of dMyc and
dMyc Downstream Targets in the Fat Body
(A and B) Measurement of larval dMyc, RpI1, RpI135, and
dCycD transcripts by qRT-PCR in dissected fat bodies
(wandering stage). Fold changes are relative to cg > W and
P0206 > W controls, respectively, and error bars represent
SEM; *p < 0.05 and **p < 0.01.
(C) Measurement of pupal volume shows that cg > dMyc and
ppl > dMyc are bigger than controls (W > dMyc, cg > W, and
ppl > W).
(D) Fat body-targeted dMyc silencing reduces pupal volume
and prevents the overgrowth observed in cg > EcR-RNAi
animals. W, EcR-RNAi, W, EcR-RNAi; dMyc-RNAi and cg >
W are used as controls. n, number of measured pupae.
Graphs represent mean ± SEM; **p < 0.01 versus controls.
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levels of peripheral IIS under various conditions of EcR signaling,
using dInR transcript levels as a readout (dInR expression is
repressed through a feedback loop by IIS; Puig et al., 2003).
SilencingEcR in fat cells was accompanied by a general reduction
of dInR expression in larval carcasses devoid of fat tissue
(Figure 3E). This downregulation was comparable to the one
observed upon increasedDILPexpression (ppl>dilp2F) or general
PI3-kinase activation (arm>PI3K; Figure 3E) and was indicative of
a global increase of IIS in peripheral larval tissues. Therefore,
although not directly involved in the molecular mechanisms taking
place in fat cells to control growth in response to EcR signaling, IIS
participates in the general growth increase in peripheral tissues.
This indicates that EcR signaling in fat cells acts on growth by
controlling the production/emission of a humoral message leading
to IIS activation in peripheral tissues. Peripheral expression of
other growth inducers such as Myc or Cyclin D was unchanged
under the same experimental conditions (Figure S4A).EcR Loss of Function in the Fat Body Induces Expression
of dMyc and Its Targets
In order to identify the downstream targets of EcR signaling in the
fat body involved in controlling growth, we compared the tran-
scriptomes of fat bodies dissected from control (cg > W) and
cg > EcR-RNAi larvae. Expression of the growth regulator dMyc
was significantly upregulated in fat cells uponEcR loss of function
(Tables S1 and S2), a result confirmed by qRT-PCR (more than
4-fold induction; Figure4A).Accordingly, anti-dMyc immunolabel-
ing detected a marked increase in dMyc protein levels in fat clones
expressing the EcR-RNAi construct (Figure 5A). This induction
was specific for fat cells, as dMyc protein levels remained1016 Developmental Cell 18, 1012–1021, June 15, 2010 ª2010 Elsevier Inc.unchanged uponEcRsilencing in other larval tissues
such as the wing imaginal discs (Figure S5A).
Under the same conditions, the expression of
several dMyc target genes (Orian et al., 2003; Pierce
et al., 2008) was also induced (dCycD, 2.4-fold;
RpI1, 2.7-fold; RpI135, 2.8-fold). dMyc and its
target genes were also significantly induced in
larvae with reduced circulating levels of ecdysone
(P0206 > PI3KDN). Conversely, the same set of
genes was moderately repressed upon high ecdy-
sone titer (P0206 > PI3K; Figure 4B). Finally, thesemanipulations had a limited effect on dMyc expression in
dissected body walls (i.e., larval tissues devoid of fat and gut)
(Figure S4B) compared to the fat body, confirming that ecdysone
regulates dMyc expression specifically in fat cells.
dMyc Expression Levels in the Fat Body Control
Organismal Size Downstream of EcR
These results prompted us to explore the role of fat-specific
dMyc in the control of body size. Overexpression of dMyc in
the fat body was sufficient to augment pupal volume (cg >
dMyc; Figure 4C), whereas silencing of dMyc in fat cells
produced smaller animals (Figure 4D). Therefore, adipose
dMyc activity regulates organismal growth. Together with our
finding that EcR signaling controls adipose dMyc expression,
this suggested that dMyc could participate in the control of
body size downstream of EcR signaling in the fat body. To test
this hypothesis, we combined the silencing of dMyc and EcR
in fat cells. Interestingly, cg > dMyc-RNAi and cg > dMyc-
RNAi/EcR-RNAi pupae were similarly smaller, indicating that
reducing dMyc function fully prevents the pupal overgrowth
observed upon EcR silencing (Figure 4D). Silencing of CycD,
a known target of dMyc, was not sufficient to prevent the effects
of EcR knockdown, suggesting that other dMyc targets are
important for this regulation (Figure S5B). This genetic interac-
tion, established in fat cells, indicates that dMyc is acting down-
stream of EcR signaling to control organism growth.
EcR Signaling Controls Ribosome Abundance
in Fat Cells
dMyc regulates cell growth in part by controlling the synthesis of
ribosomal RNA in the nucleolus and thereby ribosome
Figure 5. Fat Body-Targeted EcR Loss of Function Alters dMyc
Expression, Nucleolus Size, and Ribosome Abundance
(A)EcR silencing increases dMyc expression in the fat body. Clones of fat body
cells expressing EcR-RNAi (labeled by nlsGFP, green) (see Figures S1A and
S1B) display increased dMyc staining (red).
(B) EcR loss of function affects nucleolar size: upon EcR silencing (cells labeled
by nlsGFP, green), the nucleoli of fat cells stained with anti-fibrillarin antibodies
(red) are markedly bigger.
(C) Inhibiting EcR signaling provokes an increase in small subunit ribosome
abundance: EcR silencing (cells labeled with nlsGFP, green), reduces RpS6
content (anti-RpS6 antibodies labeled in red).
(D) Quantification of the ratio between nucleolus and cell area. n, number of fat
body cells. Graph represents mean ± SEM; **p < 0.01 versus control (nlsGFP
overexpression).
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fication of dMyc levels had a striking effect on the size of fat
cell nucleoli (Figures S7A–S7D) (Pierce et al., 2004). This was
not a consequence of the variation in cell size because the ratio
between nucleolar and cellular size was significantly altered
(Figure S6E). Silencing EcR in clones of fat cells also induced
a marked increase in nucleolus size and the ratio between nucle-
olus and cell was significantly higher compared to wild-type cells
(Figures 5B and 5D). These results suggest that in fat body cells,
the regulation of dMyc expression by EcR controls nucleolus size
and rRNA synthesis. To evaluate further the role of EcR signaling
in ribosome synthesis, we tested whether the abundance of ribo-Developmsome subunits depended on EcR signaling. For this, we used
specific antibodies against the ribosomal protein RpS6,
a component of the small ribosome subunit used as a marker
of total ribosome number (Wimberly et al., 2000). Overexpres-
sion of dMyc, used as a control, induced a marked increase of
RpS6 in fat cells (Figure S6F). Similarly, RpS6 staining was
increased upon EcR silencing (Figure 5C). These experiments
indicate that EcR signaling normally reduces ribosome number
in fat cells, and suggest that this effect relies on EcR-mediated
repression of dMyc levels.
EcR Signaling Limits dMyc Activity and Global Growth
at the Larval-Pupal Transition
Ecdysteroid rises gradually during the third larval instar, with
a sharp peak of production just before metamorphosis (Parvy
et al., 2005; Warren et al., 2006). In line with our results showing
dMyc repression by EcR signaling, we observed a decrease in
dMyc transcript levels throughout the third larval instar
(Figure 6B). During the same period, we observed that the levels
of dMyc protein decrease markedly in fat cells (Figure 6A), and
this was accompanied by a reduction of the nucleolus/cell ratio
and a marked decrease in RpS6 protein levels (Figures 6C–6E).
Silencing EcR was sufficient to prevent the decrease in dMyc
expression and to provoke an increase in nucleolus size (Figures
6B and 6D). This effect was particularly apparent at 115 hr after
egg deposition (AED), when circulating ecdysone reaches its
highest level. Therefore, the transition from larval to pupal devel-
opment is marked by a rise in 20E titers, the downregulation of
dMycexpression in the fat body, and, as a consequence, a reduc-
tion of ribosome biogenesis and protein translation in fat cells.
Together with our data demonstrating the role of adipose dMyc
in controlling organismal growth, we propose that this cascade
of developmental events is responsible for the reduction of the
growth rate that precedes entry into pupal development. In line
with this hypothesis, the modification of the protein translation
capacity of fat cells has strong effects on systemic growth: the
fat-specific knockdown of the translation initiation factor eIF-4E
reduces pupal size, whereas knocking down the translation
repressor 4E-BP in fat cells increases it (Figure S6G).
DISCUSSION
The growth rate and the duration of juvenile growth are two key
parameters that determine the size of the animal at the time of
maturation. These two parameters are coupled during the juve-
nile period to determine organismal size at maturation by mech-
anisms that are not yet understood. Recent work has established
that the two hormonal systems controlling these parameters,
ecdysone and insulin/IGF, have antagonistic actions that set
up the larval growth rate. The present study demonstrates that
the fat body is the unique relay for ecdysone-induced growth
inhibition, and provides molecular and genetic evidence that
inhibition of dMyc function by ecdysone signaling in fat cells
plays a key role in this control.
Paradoxically, we observed a positive, cell-based role for
ecdysone in growth and proliferation during larval stages.
Indeed, clonal loss of function for EcR induces a reduction of
cell size despite an increase in PI3K activity and dMyc expres-
sion. This indicates that ecdysone signaling is autonomouslyental Cell 18, 1012–1021, June 15, 2010 ª2010 Elsevier Inc. 1017
Figure 6. dMyc Expression and Activity
Decrease during the Third Larval Instar
(A) Representative images (high magnification) of
staged fat body at 72, 96, and 115 hr AED labeled
with anti-dMyc antibodies show that nuclear dMyc
staining decreases along larval development.
(B) Measurement of dMyc transcripts by qRT-PCR
in fat bodies dissected from third instar larvae.
Fold changes are relative to control (cg > W,
96 hr AED) and error bars represent SEM;
**p < 0.01 versus control.
(C) The size of fat body nucleoli progressively
diminishes during the third larval instar. Nucleoli
are labeled with anti-fibrillarin (red) and the F-actin
network with phalloidin (green).
(D) Quantification of the ratio between nucleolar
and cellular area. n, number of fat body cells.
Graph represents mean ± SEM; **p < 0.01 versus
control.
(E) Total amounts of small ribosomal subunit
decrease during the third larval instar. Represen-
tative images of staged fat body at 72, 96, and
115 hr AED are shown, stained with anti-RpS6
antibodies.
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the growth rate at the systemic level. These results are in line
with previous studies indicating that ecdysone/EcR/Usp and
some of their downstream targets are required for cell-cycle
progression (Brennan et al., 1998; Ghbeish et al., 2001; Ghbeish
and McKeown, 2002; Mitchell et al., 2008) and tissue growth
(Nijhout and Grunert, 2002). Ex vivo culture experiments using
dissected discs from Bombyx mori have shown that an optimal
concentration of 20E is required for proper disc growth that is
6- to 10-fold lower than the 20E concentration required to stim-
ulate the molting cycle (Nijhout and Grunert, 2002). This
suggests that different ecdysone concentrations are required
for cell-autonomous growth induction and nonautonomous
growth inhibition. It is likely that elevated 20E levels like those at-
tained at the end of larval development are required for the inhi-
bition of dMyc expression in the fat body, leading to systemic
growth inhibition.
Our data indicate that the fat body is central in the regulation of
organismal growth by ecdysone. Previous studies have estab-
lished that this organ acts as a nutrient sensor and coordinates
global growth according to nutrition conditions (Colombani
et al., 2003). Therefore, it appears positioned at a crossroad, al-
lowing extrinsic and intrinsic inputs to be integrated and trans-
lated into a coordinated control of body growth. Our results indi-
cate that dMyc, but not IIS, is required in the fat body for1018 Developmental Cell 18, 1012–1021, June 15, 2010 ª2010 Elsevier Inc.transducing the growth effects of EcR
signaling. Our previous work showed
that TOR signaling, and not IIS, controls
the nutrition sensor that operates in fat
body cells (Colombani et al., 2003; Ge´mi-
nard et al., 2009). Although not required in
fat cells for either of these controls, IIS is
downregulated in peripheral tissues, and
this regulation contributes to the systemicgrowth inhibition observed under both conditions. This suggests
that the fat body remotely controls the expression/production/
secretion/activity of the circulating Dilps that activate dInR. We
recently demonstrated that under conditions of abundant nutri-
ents, the fat body emits a ‘‘secretion signal’’ that triggers the
release of Dilps from brain cells (Ge´minard et al., 2009). The
molecular links proposed between TOR signaling and dMyc posi-
tion dMyc as a downstream effector of TOR signaling, playing
a role in the transcriptional activation of target genes (Teleman
et al., 2008). This and our current data suggest the possibility
that both nutrition- and ecdysone-induced signals converge on
a Myc-dependent mechanism in fat cells leading to the systemic
regulation of growth by general IIS.
Both dMyc and TOR signaling control ribosome biogenesis
and protein translation initiation. In addition to its role as an
energy reservoir, the fat body, like the mammalian liver, is one
of the most active secreting tissues, and a large majority of the
hemolymph proteins are synthesized in this tissue. This
secreting function is thought to be essential for larval growth
and is likely to be sensitive to ribosome quantity. Therefore,
the fat body could control systemic growth either via the produc-
tion of specific secreted factors according to ribosomal abun-
dance, or via the control of hemolymph protein concentration
that would in turn regulate growth. Our current studies should
help discriminate between these different hypotheses.
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edly modifies the activities of many IIS signaling actors such as
PI3K, AKT, and dFoxO (Colombani et al., 2005) (Figure S1). We
demonstrate here that this regulation does not contribute to
the control of organismal growth, suggesting that the function
of 20E-induced IIS repression at the end of larval development
is restricted to metabolic effects, such as the arrest of carbohy-
drate and lipid storage, and to the induction of autophagy
(Britton et al., 2002; Rusten et al., 2004; Scott et al., 2004).
Changing ecdysone circulating level influences dMyc expres-
sion in the fat body but not in any other larval tissues. Therefore,
the EcR-dependent control of dMyc expression is specific to this
tissue. We could not detect any consensus binding sites for EcR/
Usp in the dMyc promoter region. This suggests that dMyc is not
a direct target of EcR-mediated gene repression, but rather that
EcR signaling controls expression of a fat-specific downstream
component that is itself responsible for adipose dMyc transcrip-
tional regulation.
Myc has been recently shown to promote oxidative phosphor-
ylation as well as glycolysis through coordinate transcriptional
control of the mitochondrial metabolic network (Zhang et al.,
2007). This metabolic regulation by dMyc has not been studied
in our present work, but we can conjecture that rising ecdysone
levels at the end of the juvenile period influence both translational
and metabolic activities regulated by dMyc in the fat body,
a regulation that could have important consequences on the
energy homeostasis of the animal during this important develop-
mental transition.
In conclusion, the present work reveals an unexpected role for
dMyc in the systemic control of growth. We demonstrate that the
fat body-specific activity of dMyc is the target of EcR signaling
and is involved in a remote regulation of growth through IIS in
peripheral tissues.EXPERIMENTAL PROCEDURES
Fly Strains
W1118 flies (W) were used as controls. Fat body drivers were cg-GAL4 (Takata
et al., 2004), ppl-GAL4 (Colombani et al., 2003), and r4-GAL4 (Lee and Park,
2004). The gut driver, myo1D-GAL4, and UAS-PTEN-RNAi were from the
Drosophila Genetic Resource Center (Kyoto). tGPH (Britton et al., 2002),
UAS-PI3K and UAS-PI3KDN (Leevers et al., 1996), UAS-dMyc (Zaffran et al.,
1998), UAS-EcRF645A (Cherbas et al., 2003), and UAS-EcR-RNAi (Roignant
et al., 2003) were as described. Mitotic clones were generated using either Ac-
tin5c > CD2 > Gal4, UAS-nlsGFP (Pignoni and Zipursky, 1997) or tGPH, Actin
5c > CD2 > GAL4 lines (Britton et al., 2002). UAS-dMyc-RNAi, UAS-dFoxO-
RNAi, UAS-dCycD-RNAi, UAS-PI3K-RNAi, UAS-d4EBP-RNAi, and UAS-eIF-
4E-RNAi were obtained from the Vienna Drosophila RNAi Center. Other lines
were obtained from the Bloomington Stock Center. Animals were reared at
25C or as otherwise indicated, on fly food containing, per liter, 10 g agar,
166 g corn flour, 120 g white sugar, 34 g inactivated yeast extract, and 3.75
g Moldex M (in ethanol), supplemented with yeast paste.20E Treatments and Growth Phenotype Analysis
Larvae from different genotypes were synchronized at 24 hr AED and cultured
under controlled conditions (50 larvae/vial). Pupal volume was measured using
Photoshop (Adobe) and calculated by using the formula 4/3p(L/2)(l/2)2
(L, length; l, diameter). For 20E treatments, larvae synchronized 24 hr AED
were transferred into yeast paste daily supplemented with 0.75 mg/ml 20-hy-
droxyecdysone (Sigma) until pupariation.DevelopmImmunofluorescence on Larval Tissues
Tissues were dissected from wandering larvae or as otherwise indicated in 13
PBS, fixed in 3.7% formaldehyde (Sigma) in PBS for 20 min at room tempera-
ture, and extensively washed in PBS containing 0.3% Triton X-100 (PBT).
Tissues were then blocked for 1 hr in PBT containing 10% FCS. Primary anti-
bodies were incubated overnight at 4C. Secondary antibodies were incu-
bated for 2 hr at room temperature. DNA was stained with Hoechst 33258
(1 mM) for 20 min and membranes with FluorProbe 647-phalloidin (Interchim)
at 1/100. After washing, tissues were mounted in Vectashield (Vector Labs).
Fluorescence images were acquired using a Zeiss LSM510 Meta confocal
laser-scanning microscope (403 objectives). The following primary antibodies
were used in this study: anti-dFoxO was generated in rabbits using two
peptides containing amino acids 2–16 (MDGYAQEWPRLTHTD) and amino
acids 585–595 (AYPNSEPSSDS) (Eurogentec) and diluted at 1/500; rabbit
anti-phospho-dAKT (gift from S. Leevers) (Orme et al., 2006) at 1/100; mouse
anti-EcR (AG 10.2) (gift from C. Thummel) at 1/100; rabbit anti-dMyc (gift from
D. Stein) (Maines et al., 2004) at 1/500; mouse anti-dMyc P4C4 B10 (gift from
B. Edgar and P. Bellosta) at 1/5 (Prober and Edgar, 2000); mouse anti-RpS6
(Cell Signaling) at 1/100; mouse anti-fibrillarin (Abcam) at 1/500; and mouse
anti-rat CD2 (Serotec; MCA154) at 1/100.
Cell and nucleolus areas were measured using Photoshop (Adobe).Cell Proliferation and Clonal Growth Measurements
Larvae from 4 hr egg collections were transferred to yeasted vials at 24 hr AED.
Mitotic clones were induced using the FLP/FRT technique (Xu and Rubin,
1993; Pignoni and Zipursky, 1997). In the fat body, clones were generated
during the first larval instar due to hsp-Flp leakage at 25C and cell area (pixels)
was measured. In imaginal tissues, clones were induced at 37C for 20 min
either at 48 or 72 hr AED and were evaluated at 115 hr AED for cell count or
clone size. Cell-doubling times were derived using the formula (log2/logn)h,
where n is the median number of cells per clone and h is the age of the clone
(Neufeld et al., 1998).Quantitative RT-PCR
Larvae were collected at wandering stages (115 hr AED), or as otherwise indi-
cated. Larval fat bodies or larval body walls were dissected in 13 PBS and
frozen in liquid nitrogen. Total RNA was extracted using a QIAGEN RNeasy
lipid tissue minikit according to the manufacturer’s protocol. RNA samples
(3 mg per reaction) were treated with DNase and reverse transcribed using
SuperScript II reverse transcriptase (Invitrogen), and the generated cDNA
was used for real-time RT-PCR (StepOne Plus; Applied Biosystems) using
PowerSYBRGreen PCR mastermix (Applied Biosystems), with 8 ng of cDNA
template and a primer concentration of 300 nM. Samples were normalized
with actin 5C. Three separate samples were collected for each experiment
and triplicate measurements were conducted. For each gene, two indepen-
dent sets of primers were used. Primers were designed using PrimerExpress
software (Applied Biosystems), and their sequences are available on request.SUPPLEMENTAL INFORMATION
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